Paper Details

  1. Home
  2. Paper Details

The role of pazopanib on tumour angiogenesis and in the management of cancers: A review.

Author: ChellappanDinesh Kumar, ChellianJestin, FooJia Hui, GuptaGaurav, HangLi Yu, LingJoyce, NathanSaranyah, NgZhao Yin, SimYan Jinn, SinghYogendra, ThengChiu Wei, WongMei, YangGoh Jun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Pazopanib is a chemotherapy drug with anti-angiogenic properties, which can inhibit the growth of blood vessels that supply tumors. This review analyzed 352 studies about pazopanib and its anti-angiogenic effects in various cancers. Pazopanib showed anti-angiogenic effects in several cancers, such as renal cell carcinoma, solid tumors, and soft tissue sarcoma.
Paper Details　
Original Abstract of the Article :
Pazopanib is a relatively new compound to be introduced into the chemotherapy field. It is thought to have decent anti-angiogenic properties, which gives an additional hope for the treatment of certain types of cancers. A systematic review solely discussing about pazopanib and its anti-angiogenic ef...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.biopha.2017.10.058

データ提供：米国国立医学図書館（NLM）

Pazopanib: A New Oasis in the Desert of Cancer Treatment

The world of cancer treatment is a complex and often challenging desert, with many obstacles to overcome. This study, a comprehensive review of the anti-angiogenic properties of pazopanib, explores a new oasis of therapeutic options for individuals battling various types of cancers. The researchers, like skilled desert explorers, meticulously analyze the available data on pazopanib's anti-angiogenic effects, seeking to understand its potential impact on tumor growth and progression. Their findings highlight the promising potential of pazopanib as an anti-angiogenic agent, offering a new beacon of hope for those seeking effective treatments for certain types of cancers.

A Glimpse into the Desert of Angiogenesis

This study sheds light on the desert of angiogenesis, the process by which tumors develop their own blood supply. The researchers' analysis of pazopanib's anti-angiogenic properties suggests a potential path to disrupting tumor growth by targeting this essential process. Their findings provide valuable insights into the potential benefits of pazopanib for managing certain types of cancers, offering a ray of hope in the fight against this devastating disease.

Navigating the Desert of Cancer with Hope

The fight against cancer is a challenging journey. This study offers a beacon of hope by exploring the potential benefits of pazopanib as an anti-angiogenic agent. While further research is needed, the study's findings suggest that pazopanib could be a valuable tool in the fight against certain types of cancers, offering a new path toward effective treatments and improved outcomes for patients.

Dr.Camel's Conclusion

This research is like discovering a hidden oasis in the vast desert of cancer treatment. Pazopanib's anti-angiogenic properties offer a glimmer of hope for individuals battling various types of cancers. This study reminds us of the importance of exploring new and innovative treatment strategies to combat this devastating disease and bring hope to those seeking a cure.

Date :
  1. Date Completed 2018-07-25
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

29054093

DOI: Digital Object Identifier

10.1016/j.biopha.2017.10.058

Related Literature

Article Analysis
・Effects of pazopanib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.